SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001626199-20-000015
Filing Date
2020-05-05
Accepted
2020-05-05 16:49:28
Documents
5
Effectiveness Date
2020-05-05

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a2020.htm DEFA14A 30227
2 alpineimmunesciencesinc_na01.jpg GRAPHIC 171711
3 alpineimmunesciencesinc_na02.jpg GRAPHIC 238427
4 alpineimmunesciencesinc_na03.jpg GRAPHIC 92111
5 alpineimmunesciencesinc_na04.jpg GRAPHIC 52166
  Complete submission text file 0001626199-20-000015.txt   795578
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37449 | Film No.: 20849673
SIC: 2834 Pharmaceutical Preparations